ICTC Indian Cancer Treatment Centre – A comprehensive session dedicated to breast cancer at the AMMO confernece

ICTC Indian Cancer Treatment Centre shared on LinkedIn:

“The AMMO Conference dedicated a comprehensive session to breast cancer, featuring four insightful talks. The session began with a panel discussion on adjuvant therapy in HR+ve breast cancer, focusing on molecular tests and adjuvant CDK4/6 inhibitors, moderated by Dr. Shivam Shingla, with esteemed panelists Dr. Anbarasan Sekar, Dr. Darshana Rane, Dr. Preetam Jain, Dr. Pritam Kalaskar, and Dr. Pritam Kataria.

Next, Dr. Hemmel Amrania from Digistain UK presented on innovative technology for identifying biomarkers to predict breast cancer recurrence. This was followed by a second panel discussion on the present and future treatment landscape of Her2+ve breast cancer, moderated by Dr. Shivam Shingla, with a distinguished panel including Dr. Amit Ghanekar, Dr. Rohit Pai, Dr. Shruti Arora, Dr. Anbarasan Sekar, Dr. Vijay Sharnangat, Dr. Sandip Bipte, Dr. Suparna Rao, and Dr. Preetam Jain.

The session concluded with a discussion moderated by Dr. Rohit Pai on surgery and radiotherapy decision-making in patients with post-NACT breast carcinoma, featuring panelists Dr. Sandip Bipte, Dr. Jay Anam, Dr. Tushar Jadhav, Dr. Ridhima Bindlish, Dr. Bhavin Visariya, Dr. Dilip Nikam, and Dr. Shreyas Somnath. This session offered valuable insights and advanced discussions on the latest in breast cancer treatment and care.”

Source: ICTC Indian Cancer Treatment Centre/LinkedIn